Zoledronic acid, a once-yearly infusion, has been approved by Health Canada for treatment of postmenopausal osteoporosis. Known as Reclast in the U.S., the bisphosphonate medication received FDA approval for that purpose just a few months ago. It will be sold as Aclasta in Canada and will help provide osteoporosis patients in the country one more option for strengthening their bones.
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
What the community is saying...
Read Any Good Books On Osteoporosis Lately?
Posted 05/25 Comments (1)
Where do you go when you want to find information...
